PLXNA1 and glioblastoma: Similarly, the knockdown of Plexin-A1 in the zebrafish GBM model revealed its role in inducing both developmental and GBM tumour-specific pro-angiogenesis, identifying Plexin-A1 as a potential therapeutic target for treating GBM by blocking the pro-angiogenic effects [109].